Allergan, Inc. (NYSE: AGN) today confirmed that it has received an unsolicited proposal from Valeant Pharmaceuticals International, Inc. (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE